DE NICOLO', Amedeo
DE NICOLO', Amedeo
SCIENZE MEDICHE
A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop
2014-01-01 A. De Nicolò; A. Ciancio; L. Boglione; A. Mohamed Abdi; A. Smedile; G.P. Caviglia; G. DI Perri; M. Rizzetto; A. D'Avolio
A UHPLC-MS/MS method for the quantification of currently used direct antiviral agents in human plasma and evaluation of "normalized matrix effect"
2016-01-01 D'Avolio, A.; Ariaudo, A.; Favata, F.; De Nicolò, A.; Simiele, M.; Boglione, L.; Carcieri, C.; Di Perri, G.
A UHPLC-MS/MS Method to Quantify Tacrolimus in Tissues: Standardization Based on the Real Volume of Cells
2016-01-01 Pensi, D.; De Nicolò, A.; Favata, F.; Pisciotta, C.; Di Perri, G.; D'Avolio, A.
An UPLC MS/MS method coupled with automated on-line solid phase extraction for quantification of tacrolimus in PBMC samples
2014-01-01 Pensi D; De Nicolò A; Pinon M; Calvo PL; Di Perri G; D'Avolio A
Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study
2017-01-01 De Nicolò, A.; Boglione, L.; Carcieri, C.; Cusato, J.; Mornese Pinna, S.; Favata, F.; Ariaudo, A.; Di Perri, G.; D’Avolio, A.
Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs?
2013-01-01 Antonio D'Avolio; Amedeo De Nicolò; Marco Simiele; Lorena Baietto; Andrea Calcagno; Mauro Sciandra; Laura Trentini; Cristina Tettoni; Letizia Marinaro; Giovanni Di Perri; Stefano Bonora
Development and validation of an UPLC MS-MS method for the quantification of new direct antiretroviral agents simeprevir, daclatasvir sofosbuvir and its metabolite GS-332007 in human plasma
2014-01-01 Ariaudo A; Simiele M; De Nicolò A; Boglione L; Di Perri G; D'Avolio A
Directly active antivirals pharmacokinetics in HCV/HIV co-infected patients with advanced hepatic fibrosis
2017-01-01 Marinaro, L; Merli, M; Barco, A; Alcantarini, C; Montrucchio, C; Tettoni, Mc; Vendemiati, G; Bocchino, G; De Nicolo', A; Hasson, H; D'Avolio, A; Foppa, C.U.; Di Perri, G; Bonora, S.
Early ribavirin concentration is a critical response factor in the sub-population of patients infected by HCV-1 and unfavourable IL28B genotype
2013-01-01 Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Francesca Patti; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio
Early ribavirin plasma concentrations as predictor of anemia onset after one month of anti-HCV therapy in ITPA stratified population
2013-01-01 Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio
Evaluation of intracellular and plasma pharmacokinetics, pharmacogenetics and clinical features in HBV e antigen-negative patients treated with entecavir.
2015-01-01 Cusato, Jessica; De Nicolo’, Amedeo; Boglione, Lucio; Cardellino, Chiara Simona; Allegra, Sarah; Bonifacio, Gabriele; Cariti, Giuseppe; Giovanni Di Perri, ; D’Avolio, Antonio
F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy
2012-01-01 GP Caviglia; A D'Avolio; A Ciancio; A De Nicolò; L Boglione; ML Abate; C Rosso; A Smedile; G Cariti; J Cusato; M Simiele; M Rizzetto; G Di Perri
Gender differences in five different drug pharmacokinetics
2019-01-01 S. Allegra, S. De Francia, A. E. Sprio, M. De Gobbi, A. Piga, A. De Nicolò, M. Antonucci, A. D’Avolio, S. Racca
High four weeks’ entecavir plasma concentration is a negative predictor of HBV DNA drop after three months of therapy
2015-01-01 A. De Nicolò; L. Boglione; L. Baietto; C.S. Cardellino; M. Simiele; G. Cariti; G. Di Perri; A. D'Avolio
ITPA gene variants as markers of ribavirin-induced anemia and white blood cells reduction in Egyptian HCV patients
2015-01-01 Abdelhafez, A; Cusato, J; Hussein, A; Kamel, S; De Nicolo', A; Di Perri, G; D'Avolio, A; El Desoky, E
Pharmacokinetic and pharmacogenetic analysis of tacrolimus in pediatric liver transplant patients in the early post-liver transplantation period
2014-01-01 Calvo PL; Pinon M; Canaparo R; D’Avolio A; Brunati A; Pensi D; De Nicolò A; Carbonaro G; Cerrina A; Nonnato A; Romagnoli R; Barbera C; Salizzoni M
Pharmacokinetic of doxorubicin during chemotherapy in HIV patients affected by Hodgkin disease and Non- Hodgkin’s Lymphoma: the PKCT study
2014-01-01 A. Carbone; A. Calcagno; M. Guffanti; A. D'Avolio; L. Galli; A. De Nicolo; A. Galli; V. Castagna; A. Lazzarin; A. Castagna; N. Gianotti; S. Bonora
Quantification of tacrolimus in PBMCs samples in pediatric liver transplant patients and correlation with tacrolimus whole blood concentration
2014-01-01 Pinon M; Calvo PL; D’Avolio A; Pensi D; Brunati A; Canaparo R; De Nicolò A; Carbonaro G; Cerrina A; Di Perri G; Romagnoli R; Barbera C; Salizzoni M
Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy
2014-01-01 L. Boglione; A. De Nicolò; C. S. Cardellino; T. Ruggiero; V. Ghisetti; G. Cariti; G. Di Perri; A. D’Avolio
UHPLC-MS/MS Method with On-line SPE to Quantify Tacrolimus and Everolimus in Peripheral Blood Mononuclear Cells: Application of “IS-normalized” Matrix Effect
2016-01-01 De Nicolò, Amedeo; Pensi, Debora; Pinon, Michele; Pisciotta, Clarissa; Calvo, Pier Luigi; Nonnato, Antonello; Romagnoli, Renato; Tandoi, Francesco; Di Perri, Giovanni; D'Avolio, Antonio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A concentration-dependent pharmacokinetic interaction with telaprevir increases ribavirin concentrations and leads to higher haemoglobin drop | 2014 | A. De Nicolò; A. Ciancio; L. Boglione; A. Mohamed Abdi; A. Smedile; G.P. Caviglia; G. DI Perri; M. Rizzetto; A. D'Avolio | |
| A UHPLC-MS/MS method for the quantification of currently used direct antiviral agents in human plasma and evaluation of "normalized matrix effect" | 2016 | D'Avolio, A.; Ariaudo, A.; Favata, F.; De Nicolò, A.; Simiele, M.; Boglione, L.; Carcieri, C.; Di Perri, G. | |
| A UHPLC-MS/MS Method to Quantify Tacrolimus in Tissues: Standardization Based on the Real Volume of Cells | 2016 | Pensi, D.; De Nicolò, A.; Favata, F.; Pisciotta, C.; Di Perri, G.; D'Avolio, A. | |
| An UPLC MS/MS method coupled with automated on-line solid phase extraction for quantification of tacrolimus in PBMC samples | 2014 | Pensi D; De Nicolò A; Pinon M; Calvo PL; Di Perri G; D'Avolio A | |
| Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study | 2017 | De Nicolò, A.; Boglione, L.; Carcieri, C.; Cusato, J.; Mornese Pinna, S.; Favata, F.; Ariaudo, A.; Di Perri, G.; D’Avolio, A. | |
| Could ritonavir intracellular concentrations have a role as active drugs when used as a booster PIs? | 2013 | Antonio D'Avolio; Amedeo De Nicolò; Marco Simiele; Lorena Baietto; Andrea Calcagno; Mauro Sciandra; Laura Trentini; Cristina Tettoni; Letizia Marinaro; Giovanni Di Perri; Stefano Bonora | |
| Development and validation of an UPLC MS-MS method for the quantification of new direct antiretroviral agents simeprevir, daclatasvir sofosbuvir and its metabolite GS-332007 in human plasma | 2014 | Ariaudo A; Simiele M; De Nicolò A; Boglione L; Di Perri G; D'Avolio A | |
| Directly active antivirals pharmacokinetics in HCV/HIV co-infected patients with advanced hepatic fibrosis | 2017 | Marinaro, L; Merli, M; Barco, A; Alcantarini, C; Montrucchio, C; Tettoni, Mc; Vendemiati, G; Bocchino, G; De Nicolo', A; Hasson, H; D'Avolio, A; Foppa, C.U.; Di Perri, G; Bonora, S. | |
| Early ribavirin concentration is a critical response factor in the sub-population of patients infected by HCV-1 and unfavourable IL28B genotype | 2013 | Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Francesca Patti; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio | |
| Early ribavirin plasma concentrations as predictor of anemia onset after one month of anti-HCV therapy in ITPA stratified population | 2013 | Amedeo De Nicolò; Jessica Cusato; Lucio Boglione; Alessia Ciancio; Antonina Smedile; Danilo Agnesod; Giuseppe Cariti; Mario Rizzetto; Giovanni Di Perri; Antonio D'Avolio | |
| Evaluation of intracellular and plasma pharmacokinetics, pharmacogenetics and clinical features in HBV e antigen-negative patients treated with entecavir. | 2015 | Cusato, Jessica; De Nicolo’, Amedeo; Boglione, Lucio; Cardellino, Chiara Simona; Allegra, Sarah; Bonifacio, Gabriele; Cariti, Giuseppe; Giovanni Di Perri, ; D’Avolio, Antonio | |
| F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy | 2012 | GP Caviglia; A D'Avolio; A Ciancio; A De Nicolò; L Boglione; ML Abate; C Rosso; A Smedile; G Cariti; J Cusato; M Simiele; M Rizzetto; G Di Perri | |
| Gender differences in five different drug pharmacokinetics | 2019 | S. Allegra, S. De Francia, A. E. Sprio, M. De Gobbi, A. Piga, A. De Nicolò, M. Antonucci, A. D’Avolio, S. Racca | |
| High four weeks’ entecavir plasma concentration is a negative predictor of HBV DNA drop after three months of therapy | 2015 | A. De Nicolò; L. Boglione; L. Baietto; C.S. Cardellino; M. Simiele; G. Cariti; G. Di Perri; A. D'Avolio | |
| ITPA gene variants as markers of ribavirin-induced anemia and white blood cells reduction in Egyptian HCV patients | 2015 | Abdelhafez, A; Cusato, J; Hussein, A; Kamel, S; De Nicolo', A; Di Perri, G; D'Avolio, A; El Desoky, E | |
| Pharmacokinetic and pharmacogenetic analysis of tacrolimus in pediatric liver transplant patients in the early post-liver transplantation period | 2014 | Calvo PL; Pinon M; Canaparo R; D’Avolio A; Brunati A; Pensi D; De Nicolò A; Carbonaro G; Cerrina A; Nonnato A; Romagnoli R; Barbera C; Salizzoni M | |
| Pharmacokinetic of doxorubicin during chemotherapy in HIV patients affected by Hodgkin disease and Non- Hodgkin’s Lymphoma: the PKCT study | 2014 | A. Carbone; A. Calcagno; M. Guffanti; A. D'Avolio; L. Galli; A. De Nicolo; A. Galli; V. Castagna; A. Lazzarin; A. Castagna; N. Gianotti; S. Bonora | |
| Quantification of tacrolimus in PBMCs samples in pediatric liver transplant patients and correlation with tacrolimus whole blood concentration | 2014 | Pinon M; Calvo PL; D’Avolio A; Pensi D; Brunati A; Canaparo R; De Nicolò A; Carbonaro G; Cerrina A; Di Perri G; Romagnoli R; Barbera C; Salizzoni M | |
| Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy | 2014 | L. Boglione; A. De Nicolò; C. S. Cardellino; T. Ruggiero; V. Ghisetti; G. Cariti; G. Di Perri; A. D’Avolio | |
| UHPLC-MS/MS Method with On-line SPE to Quantify Tacrolimus and Everolimus in Peripheral Blood Mononuclear Cells: Application of “IS-normalized” Matrix Effect | 2016 | De Nicolò, Amedeo; Pensi, Debora; Pinon, Michele; Pisciotta, Clarissa; Calvo, Pier Luigi; Nonnato, Antonello; Romagnoli, Renato; Tandoi, Francesco; Di Perri, Giovanni; D'Avolio, Antonio |